Phase 3 trial results show enlicitide, a once-daily oral PCSK9 inhibitor, cut LDL cholesterol by about 60% in high-risk ...

In this interview, Technology Networks spoke to Dr. Funda Meric-Bernstam about the landscape of personalized cancer therapy.

In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of ...

Interview insights explain how GLP-1R agonists access brain regions governing reward, motivation, and stress. Animal studies ...

Researchers found that cumulative exposure to disadvantaged neighborhoods predicted faster epigenetic aging across three ...

Analysis of US diet and health data shows adults consuming the most ultra-processed foods face a 47% higher risk of heart ...

Scholars warn that replacing animal testing too quickly may threaten drug safety. As the FDA promotes AI and organoids, ...

A large genetic analysis identified 66 high-confidence genes linked to anxiety disorders across major brain regions. Findings ...

Researchers found that individuals have distinct baseline levels of brain-derived proteins in cerebrospinal fluid, masking ...

Scientists identified the gene-expression profile of sleeping nociceptors, sensory neurons that drive spontaneous neuropathic ...

Researchers showed that teosinte gene fragments in modern corn suppress nitrifying and denitrifying soil bacteria, reducing ...

Researchers identified FABP4 as a driver of MASLD-related liver cancer. They developed a monoclonal antibody that neutralizes ...